These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12102580)

  • 1. Role of genomics in identifying new targets for cancer therapy.
    Anzick SL; Trent JM
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):7-13. PubMed ID: 12102580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate gene approach for pharmacogenetic studies.
    Ring HZ; Kroetz DL
    Pharmacogenomics; 2002 Jan; 3(1):47-56. PubMed ID: 11966402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perspectives on postgenome medicine: Cancer].
    Yano K; Miki Y
    Nihon Rinsho; 2001 Jan; 59(1):31-7. PubMed ID: 11197858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of genomic tools to colorectal cancer therapeutics.
    Auman JT; McLeod HL
    Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies.
    De La Vega FM; Dailey D; Ziegle J; Williams J; Madden D; Gilbert DA
    Biotechniques; 2002 Jun; Suppl():48-50, 52, 54. PubMed ID: 12083398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer genomics: promises and complexities.
    Zhang W; Labordé PM; Coombes KR; Berry DA; Hamilton SR
    Clin Cancer Res; 2001 Aug; 7(8):2159-67. PubMed ID: 11489789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of expression genomics for predicting treatment response in cancer.
    Chin KV; Alabanza L; Fujii K; Kudoh K; Kita T; Kikuchi Y; Selvanayagam ZE; Wong YF; Lin Y; Shih WC
    Ann N Y Acad Sci; 2005 Nov; 1058():186-95. PubMed ID: 16394136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C; Caldas C
    Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomic medicine. Polymorphisms and microarray applications].
    Spalvieri MP; Rotenberg RG
    Medicina (B Aires); 2004; 64(6):533-42. PubMed ID: 15637833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
    Bernig T; Chanock SJ
    Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semi-automated system for analysis and storage of SNPs.
    Lehnert V; Holzwarth J; Ott M; Thompson A; Demmak S; Foernzler D
    Hum Mutat; 2001 Apr; 17(4):243-54. PubMed ID: 11295821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the human genome and the inherited basis of common disease.
    Gabriel S
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S46-9. PubMed ID: 17178287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of emerging genomics and proteomics technologies in cancer drug target discovery.
    Onyango P
    Curr Cancer Drug Targets; 2004 Mar; 4(2):111-24. PubMed ID: 15032664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer genomics and pathology: all together now.
    Shibata T
    Pathol Int; 2012 Oct; 62(10):647-59. PubMed ID: 23005591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomic technologies in medicine].
    Aburatani H
    Nihon Rinsho; 2009 Jun; 67(6):1156-63. PubMed ID: 19507507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population genetic tools: application to cancer.
    Gabriel S
    Semin Oncol; 2007 Apr; 34(2 Suppl 1):S21-4. PubMed ID: 17449348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.